{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:14:14Z","timestamp":1788261254598,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015160","name":"Hologic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T21:04:58Z","timestamp":1720213498000},"page":"2834-2843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-9491","authenticated-orcid":false,"given":"Marc","family":"Blondon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lansiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Dongala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Pavoncello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chatellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Claver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Martinez de Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Hugon-Rodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.06.019_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.06.019_bib2","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1538-7836.2011.04468.x","article-title":"Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity","volume":"9","author":"Wik","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"Suppl","key":"10.1016\/j.jtha.2024.06.019_bib3","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.06.019_bib4","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.06.019_bib5","unstructured":"Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No. 37a. https:\/\/www.rcog.org.uk\/media\/qejfhcaj\/gtg-37a.pdf; 2015. [accessed August 1, 2024]."},{"key":"10.1016\/j.jtha.2024.06.019_bib6","first-page":"697","article-title":"Efficacy of postpartum pharmacologic thromboprophylaxis: a systematic review and meta-analysis","volume":"141","author":"Oakes","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.06.019_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.15166","article-title":"Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis","volume":"19","author":"Gassmann","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.019_bib8","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/jth.14568","article-title":"Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population","volume":"17","author":"O'Shaughnessy","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.019_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2015.12.015","article-title":"Women\u2019s values and preferences and health state valuations for thromboprophylaxis during pregnancy: a cross-sectional interview","volume":"140","author":"Bates","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.06.019_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamainternmed.2013.563","article-title":"Estimating quality of life in acute venous thrombosis","volume":"173","author":"Hogg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.06.019_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10198-015-0740-7","article-title":"The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation","volume":"17","author":"Matza","year":"2016","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jtha.2024.06.019_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"Mismetti","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.jtha.2024.06.019_bib13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery","volume":"318","author":"Collins","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.06.019_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A\u00a0comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.06.019_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2011.08956.x","article-title":"Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study","volume":"156","author":"Sultan","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.06.019_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200332","article-title":"Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients","volume":"2","author":"Mottier","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jtha.2024.06.019_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2393-12-40","article-title":"Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol","volume":"12","author":"Alonso-Coello","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jtha.2024.06.019_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.thromres.2016.04.004","article-title":"Low molecular weight heparin to prevent postpartum venous thromboembolism: a pilot study to assess the feasibility of a randomized, open-label trial","volume":"142","author":"Rodger","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.06.019_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1160\/TH14-06-0485","article-title":"Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial","volume":"113","author":"Rodger","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100671","article-title":"Preventing postpartum venous thromboembolism with low-molecular-weight heparin: a feasibility randomized controlled trial","volume":"7","author":"Blondon","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.019_bib23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1160\/TH04-02-0075","article-title":"Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences","volume":"92","author":"Locadia","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.019_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.bjc.6603804","article-title":"Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (\u2018Arimidex\u2019, tamoxifen alone or in combination) trial","volume":"97","author":"Mansel","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtha.2024.06.019_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9483-6","volume":"106","author":"Locker","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtha.2024.06.019_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.AOG.0000133481.74113.f3","article-title":"Tamoxifen for breast cancer prevention: a framework for clinical decisions","volume":"104","author":"Cykert","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2024.06.019_bib27","first-page":"160","article-title":"Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals","volume":"12","author":"Morimoto","year":"2002","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.jtha.2024.06.019_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.apmr.2011.08.039","article-title":"Examination of assumptions in using time tradeoff and standard gamble utilities in individuals with spinal cord injury","volume":"93","author":"Lin","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jtha.2024.06.019_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2796.1999.00535.x","article-title":"A\u00a0decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke","volume":"246","author":"Hallan","year":"1999","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jtha.2024.06.019_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hec.688","article-title":"A\u00a0new explanation for the difference between time trade-off utilities and standard gamble utilities","volume":"11","author":"Bleichrodt","year":"2002","journal-title":"Health Econ"},{"key":"10.1016\/j.jtha.2024.06.019_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jclinepi.2007.03.001","article-title":"The standard gamble showed better construct validity than the time trade-off","volume":"60","author":"Puhan","year":"2007","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:53:40Z","timestamp":1739480020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003805"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.019","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-PostPartum study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}